1-2 of 2
caplacizumab
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis

Clinical Trials & Observations
Flora Peyvandi, Spero Cataland, Marie Scully, Paul Coppo, Paul Knoebl, Johanna A. Kremer Hovinga, Ara Metjian, Javier de la Rubia, Katerina Pavenski, Jessica Minkue Mi Edou, Hilde De Winter, Filip Callewaert
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2137–2141.
https://doi.org/10.1182/bloodadvances.2020001834
Published: 2021
Includes: Supplemental data
Journal Articles

ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP

Clinical Trials & Observations
Linus A. Völker, Jessica Kaufeld, Wolfgang Miesbach, Sebastian Brähler, Martin Reinhardt, Lucas Kühne, Anja Mühlfeld, Adrian Schreiber, Jens Gaedeke, Markus Tölle, Wolfram J. Jabs, Fedai Özcan, Silke Markau, Matthias Girndt, Frederic Bauer, Timm H. Westhoff, Helmut Felten, Martin Hausberg, Marcus Brand, Jens Gerth, Markus Bieringer, Martin Bommer, Stefan Zschiedrich, Johanna Schneider, Saban Elitok, Alexander Gawlik, Anja Gäckler, Andreas Kribben, Vedat Schwenger, Ulf Schoenermarck, Maximilian Roeder, Jörg Radermacher, Jörn Bramstedt, Anke Morgner, Regina Herbst, Ana Harth, Sebastian A. Potthoff, Charis von Auer, Ralph Wendt, Hildegard Christ, Paul T. Brinkkoetter, Jan Menne
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3093–3101.
https://doi.org/10.1182/bloodadvances.2020001987
Published: 2020
Includes: Supplemental data